Previous Close | 1.0700 |
Open | 1.0800 |
Bid | 1.1400 x 1000 |
Ask | 1.2000 x 2200 |
Day's Range | 1.0500 - 1.1100 |
52 Week Range | 0.9750 - 2.0400 |
Volume | |
Avg. Volume | 92,883 |
Market Cap | 33.135M |
Beta (5Y Monthly) | -0.70 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.2000 |
Earnings Date | May 09, 2024 - May 13, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 2.50 |
Subscribe to Yahoo Finance Plus to view Fair Value for CODX
Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that Co-Dx CEO Dwight Egan will deliver the keynote address at the 5th Annual Infectious Disease Diagnostics and Molecular Diagnostics Conference, organized by MarketsandMarkets and held March 21-22, 2024, in London, England.
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
Co-Diagnostics ( NASDAQ:CODX ) Full Year 2023 Results Key Financial Results Net loss: US$35.3m (loss widened by 148...